Intrinsic resistance to ROS1 inhibition in a patient with CD74 ‐ROS1 mediated by AXL overexpression

ConclusionsIn summary, we demonstrate that AXL overexpression is a mechanism of intrinsic resistance to ROS1 inhibitors.

Source: Thoracic Cancer - September 20, 2023 Category: Cancer & Oncology Authors: Tara L. Peters, Nan Chen, Logan C. Tyler, Anh T. Le, Anastasios Dimou, Robert C. Doebele Tags: ORIGINAL ARTICLE Source Type: research